Synonyms: | |
Status: | Approved (1993) |
Entry Type: | Small molecule |
Molecule Category: | Parent Prodrug |
ATC: | C09AA04 |
UNII: | Y5GMK36KGY |
InChI Key | IPVQLZZIHOAWMC-QXKUPLGCSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.47 |
AlogP | 1.94 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 95.94 |
Molecular species | ACID |
Aromatic Rings | 0.0 |
Heavy Atoms | 26.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Metallo protease
Metallo protease MAE clan
Metallo protease M2 family
|
- | 2 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
Cardiomyopathy, Dilated | 3 | D002311 | ClinicalTrials |
Hypertension | 3 | D006973 | ClinicalTrials |
Marfan Syndrome | 3 | D008382 | ClinicalTrials |
Alzheimer Disease | 2 | D000544 | ClinicalTrials |
Aortic Aneurysm, Abdominal | 2 | D017544 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 1 | D013313 | ClinicalTrials |
Amphetamine-Related Disorders | 1 | D019969 | ClinicalTrials |
Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 82834-16-0 |
ChEBI | 8024 |
ChEMBL | CHEMBL1581 |
DrugBank | DB00790 |
DrugCentral | 2108 |
EPA CompTox | DTXSID6023440 |
FDA SRS | Y5GMK36KGY |
Human Metabolome Database | HMDB0014928 |
Guide to Pharmacology | 6367 |
KEGG | C07706 |
PharmGKB | PA450877 |
PubChem | 107807 |
SureChEMBL | SCHEMBL16205 |
ZINC | ZINC000003812867 |